These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30444977)

  • 21. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
    Hall BS; Meredith EL; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Trypanosoma cruzi Proteasome Inhibitors Using a Luminescence-Based High-Throughput Screening Assay.
    Zmuda F; Sastry L; Shepherd SM; Jones D; Scott A; Craggs PD; Cortes A; Gray DW; Torrie LS; De Rycker M
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity.
    Worku N; Stich A; Daugschies A; Wenzel I; Kurz R; Thieme R; Kurz S; Birkenmeier G
    PLoS One; 2015; 10(9):e0137353. PubMed ID: 26340747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).
    Woodring JL; Bland ND; Ochiana SO; Campbell RK; Pollastri MP
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5971-4. PubMed ID: 24042005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating mammalian tyrosine phosphatase inhibitors as potential 'piggyback' leads to target Trypanosoma brucei transmission.
    Ruberto I; Szoor B; Clark R; Matthews KR
    Chem Biol Drug Des; 2013 Feb; 81(2):291-301. PubMed ID: 23066974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
    Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
    Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanocidal and leishmanicidal activity of six limonoids.
    Steverding D; Sidjui LS; Ferreira ÉR; Ngameni B; Folefoc GN; Mahiou-Leddet V; Ollivier E; Stephenson GR; Storr TE; Tyler KM
    J Nat Med; 2020 Jun; 74(3):606-611. PubMed ID: 32277328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitrypanosomal activities of proteasome inhibitors.
    Nkemngu NJ; Rosenkranz V; Wink M; Steverding D
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2038-40. PubMed ID: 12019136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase.
    Terán D; Hocková D; Česnek M; Zíková A; Naesens L; Keough DT; Guddat LW
    Sci Rep; 2016 Oct; 6():35894. PubMed ID: 27786284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.
    Urbaniak MD; Mathieson T; Bantscheff M; Eberhard D; Grimaldi R; Miranda-Saavedra D; Wyatt P; Ferguson MA; Frearson J; Drewes G
    ACS Chem Biol; 2012 Nov; 7(11):1858-65. PubMed ID: 22908928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei.
    Steverding D; Wang X; Sexton DW
    Parasitol Res; 2009 Oct; 105(5):1333-8. PubMed ID: 19609563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a multicatalytic proteinase complex (20S proteasome) from Trypanosoma brucei brucei.
    Lomo PO; Coetzer TH; Lonsdale-Eccles JD
    Immunopharmacology; 1997 Jun; 36(2-3):285-93. PubMed ID: 9228559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents.
    Nanavaty V; Lama R; Sandhu R; Zhong B; Kulman D; Bobba V; Zhao A; Li B; Su B
    PLoS One; 2016; 11(1):e0146289. PubMed ID: 26771307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
    Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of
    Balogun EO; Inaoka DK; Shiba T; Tsuge C; May B; Sato T; Kido Y; Nara T; Aoki T; Honma T; Tanaka A; Inoue M; Matsuoka S; Michels PAM; Watanabe YI; Moore AL; Harada S; Kita K
    FASEB J; 2019 Nov; 33(11):13002-13013. PubMed ID: 31525300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.